# Chemomab Therapeutics Ltd.: Form 6-K, filed Aug 14, 2023

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: 6-K
- Filed: 2023-08-14
- Accepted by EDGAR: Aug 14, 2023, 08:05 ET
- Period: 2023-06-30
- Accession: 0001178913-23-002860
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002860/zk2330149.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000117891323002860/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000117891323002860/zk2330149.htm

Filed Aug 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001178913-23-002860. Last ingested by Listed: Nov 3, 2026, 08:33 ET. No prices; not investment advice.